We are incre­dibly happy to announce that Imvi Labs have been granted SEK 300,000 in plan­ning grants from Vinnova. The grant is a vital part of our con­ti­nued com­mit­ment to develop and inter­na­tio­na­lize our tech­no­logy plat­form, which enhan­ces visual atten­tion and ver­gence, with a par­ticu­lar focus on helping people who expe­ri­ence ver­gence pro­blems after con­cus­sion or stroke.

Our exis­ting product, Imvi Read, has already proven suc­cess­ful for indi­vi­du­als and schools, where it has been used to help people with dyslexia, reading and writing dif­ficul­ties, and ADHD.

With this grant, we can now take the next step and further develop the Imvi Pro plat­form to reach a wider market in healt­h­care. Our goal is to offer an effective solu­tion for reha­bi­li­ta­ting ver­gence pro­blems, which is often over­looked despite its poten­tial to have a major impact on the quality of life for those affec­ted.

The funding from Vinnova enables us to carry out impor­tant pre­pa­ra­tions for an inter­na­tio­nal appli­ca­tion to the Eurostars program in the fall of 2025. We see this as a recog­ni­tion of our inno­va­tive strength and poten­tial, and we are con­vin­ced that Imvi Pro has the poten­tial to make a big dif­fe­rence for people all over Europe. By focu­sing on ver­gence pro­blems after con­cus­sion and stroke, we hope to con­tri­bute to faster and more effective reha­bi­li­ta­tion for these patient groups. A country that is at the fore­front is Great Britain, which has intro­du­ced natio­nal gui­de­li­nes for binocu­lar vision assess­ments after stroke.

We look forward to sharing more infor­ma­tion about the project and our pro­gress!